Insider filing · ABT
Robert B Ford
CHAIRMAN AND CEO
profile →
Abbott Laboratories
ABT · Healthcare · 62 filings in 24 months
ticker →
Robert B Ford sold $46.2M of Abbott Laboratories (ABT)
Executed Aug 25, disclosed Aug 27, 2 days later.
Value, as filed
$46.2M
398,832 sh across 2 lots
Executed
Aug 25
the trade date, as filed
Disclosed
Aug 27
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RFRobert B Ford (CHAIRMAN AND CEO) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Abbott Laboratories (ABT). Across 1 priced purchase filing, the average 21-session return was +6.5% from execution and +6.3% from disclosure (delay-adjusted; derived). The largest single filing was $46.2M of ABT (398,832 sh across 2 lots, as filed), executed Aug 25.
The name
ABTHealthcare · Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Robert B Ford in ABT
ABTPURCHASE
Abbott Laboratories
$2.0M18,800 sh × $107.13
Exec Jan 23
Filed Jan 26 · 8:02 AM ET ABTSALE Abbott Laboratories $37.4M
285,388 sh × $131.17
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET ABTSALE Abbott Laboratories $16.5M
141,679 sh across 2 lots
Exec Sep 12 2024
Filed Sep 13 2024 · 5:30 PM ET